Czechia – Antineoplastic agents – LP s obsahem trastuzumabu 2026
Fakultní nemocnice Olomouc
Buyer country
Czechia
Publication date
Not specified
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 100%
- Official title coverage
- 7 languages
- Classification signal
- 33652100
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Chequia – Agentes antineoplásicos – LP s obsahem trastuzumabu 2026
Tsjechië – Antineoplastische middelen – LP s obsahem trastuzumabu 2026
Czechy – Środki przeciwnowotworowe – LP s obsahem trastuzumabu 2026
Tchéquie – Antinéoplasiques – LP s obsahem trastuzumabu 2026
Tschechien – Antineoplastische Mittel – LP s obsahem trastuzumabu 2026
Cechia – Agenti antineoplastici – LP s obsahem trastuzumabu 2026
Czechia – Antineoplastic agents – LP s obsahem trastuzumabu 2026
What Biderra adds
For notice 592420-2026, Biderra has normalized the contracting authority country as Czechia, grouped CPV 33652100 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.